Welcome : Guest

E-CLINICAL TRIAL TECHNOLOGIES - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for e-Clinical Trial Technologies in US$ Million. The Global market for “e-Clinical Trial Technologies” in this report is analyzed by the following Segments: Electronic Data Capture (EDC) Solutions, Clinical Trial Management System (CTMS), Electronic Patient Reported Outcome (ePRO), and Randomization and Trial Supply Management (RTSM). The Global “Electronic Data Capture (EDC)” Market in this report is analyzed by the following Clinical Trial Phase: Phase I, Phase II, Phase III, and Phase IV. The Global “Clinical Trial Management System (CTMS)” Market in this report is analyzed by the following Product Type: Web-based CTMS, Cloud-based CTMS, and On-Premise CTMS. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 84 companies including many key and niche players such as -

Almac Group
ArisGlobal LLC
BioClinica
Clinipace Worldwide
Cmed Technology Ltd.
DATATRAK International, Inc.

Click here to request a full list of companies covered in the report...

Code: MCP-6744
Price: $4950
Companies: 84
Pages: 321
Date: January 2018
Market Data Tables: 52
  Status: * New Report



TABLE OF CONTENTS


  E-CLINICAL TRIAL TECHNOLOGIES (Complete Report) Pages : 321   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   A Prelude.....II-1
Table 1: Increase in R&D Costs of a New Approved Drug: 1980s to 2010s.....II-1
Cost-Containment: An Important Factor Increasing the Uptake of e-Clinical Trial
  Technologies.....II-1
2$350
   Table 2: Number of Companies with Active Pipelines: 2010 to 2017 (includes corresponding Graph/Chart).....II-3

Table 3: Top Ten Pharma Companies based on Number of Drugs in Pipeline: 2017 (includes corresponding Graph/Chart).....II-3
1$350
   Global Market Overview.....II-4
Increasing Investments in Clinical Research Drive the Global e-Clinical solutions
  Market.....II-4
Table 4: Global Pharmaceutical R&D Spending (US$ Billion) for the Years 2010 through 2017 (includes corresponding Graph/Chart).....II-4
2$350
   Clinical Trials Adopt Technologies for Various Phases.....II-6
e-Clinical Trial Technologies Market by Delivery Mode.....II-6
Major Players.....II-6
1$100
   Market Gravitates from Developed Countries to Developing Countries.....II-7
Table 5: Distribution of Clinical Trials by Location: As of January 09, 2018 (includes corresponding Graph/Chart).....II-7
1$350
   Table 6: Cost of Patient Visits in Select Countries (2016): A Comparison (includes corresponding Graph/Chart).....II-81$350
   Table 7: Cost Per Patient Per Visit in Select Countries: 2016 (includes corresponding Graph/Chart).....II-9
Outsourcing of Clinical Studies to Developing Countries Benefits Market.....II-9
1$350
   Globalization Boosts e-Clinical Trials Market.....II-10
Table 8: Total Number of Registered Clinical Studies: 2010-2017 (As of December 11, 2017) (includes corresponding Graph/Chart).....II-10
1$350
   Table 9: Total Number of Registered Clinical Trials with Results posted Worldwide: 2010-2017 (As of December 11, 2017) (includes corresponding Graph/Chart).....II-111$350
   Table 10: Total Number of Studies based on Region: 2017 (As of December 11, 2017) (includes corresponding Graph/Chart).....II-12
Key Challenges for e-Clinical Trials.....II-12
1$350
   Role of Contract Research Organizations (CROs) in Clinical Activity.....II-13
Major CROs with Internally Developed CTMS Systems.....II-13
1$100
   CRO Acquisitions: Clinical Trial Technologies.....II-141$100
   Electronic Data Capture (EDC).....II-15
EDC Segment Witnesses Rapid Growth.....II-15
1$100
   Table 11: Increasing Clinical Trial Failure Rate: 1990 and 2010 (includes corresponding Graph/Chart).....II-161$350
   Table 12: Estimated Share of Electronic Data Capture Usage for New Drug Trials (includes corresponding Graph/Chart).....II-17
EDC Platforms Utilized by Select CROs.....II-17
1$350
   Competition.....II-18
Medidata Solutions Inc. – A Leading EDC Provider.....II-18
1$100
   Select Customers of Medidata's Rave.....II-191$100
   Select Customers of Oracle’s EDC.....II-20
Factors influencing EDC Selection.....II-20
Vendors Track Record.....II-20
Regulatory Compliance.....II-20
Data Security Standards.....II-20
1$100
   Trend towards Third-Party EDC Systems Gains Momentum.....II-211$100
   EDCs Boost Use of Clinical Trials.....II-22
EDC for Monitoring Patient Logistics.....II-22
EDC and Direct Monitoring of Patients.....II-22
EDC for Managing Medical Records.....II-22
1$100
   Clinical Trial Management Systems (CTMS) Market.....II-23
Tangible Cost-Savings Bolster Rapid Uptake of CTMS Solutions.....II-23
1$100
   Web-based Systems Dominate, Cloud-Based to Witness Fastest Growth.....II-24
Increased Demand for Cloud-based and Other Advanced CTMS.....II-24
1$100
   Key Players in the CTMS Market.....II-251$100
   Select Major Clinical Trial Management Systems (CTMS) Providers Worldwide.....II-26
Impact of CTMS and other Services on Pharma Industry.....II-26
Electronic Patient Record Outcome (ePRO).....II-26
Electronic Patient Record (ePRO) Solutions Replace Paper–Based PRO systems.....II-26
2$200
   Select ePRO Vendors.....II-28
Major Technology Trends Expected to Revolutionize the ePro Market.....II-28
1$100
   Big Data.....II-29
Wearable Health Trackers Becoming Mainstream.....II-29
BYOD Strategy.....II-29
Growing Usage of Tablets and Mobile.....II-29
1$100
   Real-time Feedback and Insights.....II-30
Adopting Cloud and Multi-tenant SaaS.....II-30
Consumerization of User Experience.....II-30
ePatient-Reported Outcomes (PROs) Gain Importance in Oncology Studies.....II-30
2$200
   Randomization and Trial Supply Management (RTSM).....II-32
Preference Grows for Customized/Configured RTSM.....II-32
Interactive Voice Response System (IVRS).....II-32
Multifarious Operational Benefits Drive IVRS Adoption.....II-32
1$100
   Globalization of Clinical Trials Throws Up Challenges for IVR/IWR System
  Developers.....II-33
2$200
   Surging Global Population Offers Increased Growth Opportunities.....II-35
Table 13: Top 25 Countries Worldwide in Terms of Population: 2015 & 2016 (In Million) (includes corresponding Graph/Chart).....II-35
1$350
   Pharmaceutical Firms and CROs to Drive Adoption Rate.....II-36
Rise in Clinical Trial Complexities Propels e-Clinical Trial Technologies
  Demand.....II-36
Table 14: Increasing Complexity of a Typical Phase 3 Clinical Trial: 2002 Vs. 2012.....II-36
1$350
   CROs – The Targeted Customers for e-Clinical Trial Technologies.....II-37
Table 15: Leading CROs Worldwide by Revenue: 2016 (includes corresponding Graph/Chart).....II-37
1$350
   Outsourcing of R&D Projects to Propel CRO Market, Driving Demand.....II-38
Table 16: Global Biopharma % R&D Outsourcing (2014-2020) (includes corresponding Graph/Chart).....II-38
1$350
   Noteworthy Contracts of Major CROs.....II-39
CROs Adept with New Technologies to See More Business in Future.....II-39
1$100
   Increased Importance of e-Clinical Integration.....II-401$100
   Big Data and Patient Centricity: Areas to Increase Focus Upon.....II-41
Table 17: Percentage of Companies Utilizing Advanced Technologies in Clinical Trials (includes corresponding Graph/Chart).....II-41
1$350
   Table 18: Utilization of Advanced Technologies in Clinical Trials across North America and Europe (includes corresponding Graph/Chart).....II-42
Esource Documentation Witnesses Increased Traction.....II-42
1$350
   Increased Adoption of electronic Trial Master File (eTMFs).....II-43
Risk-Based Monitoring Witnesses New Modifications.....II-43
1$100
   Growing Implementation of e-Consent.....II-44
Increased Investments in Virtual Clinical Trials.....II-44
1$100
   Open Source – Emerging Solutions in Clinical Trials Domain.....II-45
Select Open Source Technologies for Clinical Trials by Application Area.....II-45
Benefits over Proprietary Technologies to Encourage Adoption.....II-45
1$100
   EDC- The Most Attractive Application for Open Source.....II-46
Conversion to CDISC – An Emerging Application for Open Source Solutions.....II-46
Mobile Technologies to Help Trial Operators in Tackling Challenges.....II-46
1$100
   Table 19: Smartphone Penetration as a Proportion (%) of Total Mobile Users in Select Countries (2017) (includes corresponding Graph/Chart).....II-471$350
   Table 20: World Smartphones Market by Region/ Country (2016): Percentage Breakdown of Annual Unit Shipments for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Middle East & Africa (includes corresponding Graph/Chart).....II-48

Table 21: 4G Network Availability (In %) in Select Countries (2016) (includes corresponding Graph/Chart).....II-48
1$350
   Table 22: Average 4G Network Speeds (in Mbps) in Select Countries (2016) (includes corresponding Graph/Chart).....II-491$350
   Smartphones & Tablets: The New Age ePRO Devices.....II-502$200
   Defining e-Clinical Trials.....II-52
e-Clinical Solutions Enhance Clinical Trial Efficiency.....II-52
Key Advantages offered by Integrated e-Clinical Solutions include:.....II-52
Effective Deployment of an e-Clinical Solution.....II-52
1$100
   Enterprise-Level Benefits.....II-53
Benefits Offered by e-Clinical Trials.....II-53
Transparency.....II-53
1$100
   Dynamic Program Management.....II-54
Effective Trial Drug Supply.....II-54
Effective Study Randomization.....II-54
Enhanced Collaboration.....II-54
Dynamic Site Management.....II-54
Less Frequent Investigational Site Visits.....II-54
1$100
   Faster Go No-Go Decisions.....II-55
Better Planning.....II-55
Regulatory Compliance.....II-55
CDISC Standards.....II-55
Clinical Trials – In a Nutshell.....II-55
1$100
   Summarization of Clinical Trial Phases & Time Line for Drug Development.....II-56
Systems Used in e-Clinical Trials.....II-56
Electronic Data Capture Solutions (EDC).....II-56
Benefits of EDC.....II-56
1$100
   EDC and Paper CRFs – A Comparison.....II-57
Recent Advancements in EDC.....II-57
1$100
   Clinical Trial Management System (CTMS).....II-581$100
   CDMS to CTMS: The Evolutionary Move to eDevelopment.....II-59
CROs - The Targeted Customers for CTMS.....II-59
Clinical Trial Image Management System (CTMS).....II-59
1$100
   Electronic Patient Reported Outcome (ePRO).....II-60
Electronic Diaries.....II-60
Randomization and Trial Supply Management (RTSM).....II-60
1$100
   Interactive Voice Response Systems (IVRS).....II-611$100
   Technologies Used in IVR.....II-62
Interactive Web Response Systems (IWRS).....II-62
2$200
   ArisGlobal Introduces LifeSphere Clinical.....II-64
Oracle Health Sciences Unveils Oracle Clinical One.....II-64
MedNet Solutions Introduces iMedNet.....II-64
Prelude Dynamics Introduces Two Solutions.....II-64
PAREXEL Unveils Patient Sensor Solution.....II-64
Prelude Dynamics Introduces VISION 9.....II-64
Veeva Systems Unveils Veeva Vault EDC and eSource.....II-64
1$100
   Bioclinica Introduces Safety and Regulatory Software Products.....II-65
DZS Clinical Services Unveils ClinPlus 3.1e-Clinical Software.....II-65
Bioclinica Introduces OnPoint Direct.....II-65
Bioclinica Demonstrates EDC System from EHR to CDASH CRFs.....II-65
BioClinica Introduces e-Clinical CRO Partner Alliance Program.....II-65
DATATRAK Introduces UX CTMS 360.....II-65
1$100
   Novum Selects OmniComm’s TrialMaster EDC.....II-66
OmniComm Inks Contract with Beijing Hospital of the Ministry of Health.....II-66
Montrium Partners with MAPS.....II-66
MedNet Solutions Partners with arivis.....II-66
OmniComm Systems Secures EU-U.S. Privacy Shield Certification.....II-66
SRD Selects OmniComm’s TrialMaster EDC Technology.....II-66
1$100
   AB Cube Joins Health App xChange.....II-67
Anju Software Acquires ClinPlus.....II-67
DATATRAK Partners with Sisense.....II-67
Orbita Collaborates with ERT.....II-67
MedNet Solutions Obtains Privacy Shield Certification.....II-67
Medidata Acquires Mytrus.....II-67
Medidata Partners with Karyopharm.....II-67
1$100
   OmniComm Collaborates with Bio-Optronics.....II-68
OmniComm Systems Signs Agreement with MediStat.....II-68
OmniComm Signs Landmark Contracts with Major Clinical Research Organizations.....II-68
Almac Group Collaborates with Exostar.....II-68
ERT Takes Over Exco InTouch.....II-68
Almac Group Partners with inVentiv Health.....II-68
OmniComm Provides EDC Services to a Major Research Hospital.....II-68
1$100
   Bracket Acquires CLINapps.....II-69
e-ClinicalHealth Collaborates with Clinerion.....II-69
Orbus Therapeutics Selects DSG to Provide Fully Supported eCaseLink EDC System.....II-69
Cinven Acquires Bioclinica.....II-69
Top 15 Pharma Company Selects TrialOne to Automate its Entire Phase I/BA & BE
  Clinic.....II-69
Parallel 6 Joins Bioclinic’s eHealth App xChange.....II-69
Pfizer Selects Oracle’s Clinical Trial Technologies.....II-69
1$100
   IMS Health Merges with Quintiles.....II-70
OmniComm System Inks five-year, Multi-Million Dollar Agreement with CROMSOURCE.....II-70
OmniComm Inks Agreement with Canadian Pharmaceutical Drug Developer.....II-70
Bioclinica Provides RBM Solution for Clinical Trials.....II-70
Bioclinica Takes Over Clinverse.....II-70
Parallel 6 Acquires nPruv.....II-70
Clinlogix Partners with MedNet Solutions.....II-70
1$100
   OmniComm Inks five year, Multi-Million Dollar Agreement with Major CRO.....II-71
Global Biopharmaceutical Selects TrialMaster EDC for CNS Drug Trials.....II-71
Integrium Inks Licensing Agreement for DSG’s eCaseLink Solutions & Services.....II-71
BioClinica Partners with Kinapse.....II-71
ERT Acquires Boston-based PHT Corporation.....II-71
Clinical Ink Mergers with CentrosHealth.....II-71
PRA Health Sciences Acquires Value Health Solutions.....II-71
OmniComm Systems Buys IRT Technology From Clinquest.....II-71
1$100
   Almac Group (UK).....II-72
ArisGlobal LLC (USA).....II-72
1$100
   BioClinica (USA).....II-731$100
   Clinipace Worldwide (USA).....II-741$100
   Cmed Technology Ltd (UK).....II-751$100
   DATATRAK International, Inc. (USA).....II-76
DSG Inc. (USA).....II-76
1$100
   DZS Software Solutions, Inc. (USA).....II-77
eResearch Technology, Inc. (USA).....II-77
1$100
   IBM Watson Health (USA).....II-78
Medidata Solutions, Inc. (USA).....II-78
1$100
   MedNet Solutions (USA).....II-791$100
   Nextrials Inc. (USA).....II-80
OmniComm Systems, Inc. (USA).....II-80
1$100
   Oracle Corp. (USA).....II-811$100
   PAREXEL International Corp. (USA).....II-821$100
   PAREXEL Informatics Inc (USA).....II-83
Prelude Dynamics LLC (USA).....II-83
SAS Institute Inc. (USA).....II-83
1$100
   Target Health Inc. (USA).....II-841$100
   Table 23: World Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Geographic Region - US, Canada, Europe, Asia-Pacific (Including Japan), and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-851$350
   Table 24: World Historic Review for e-Clinical Trial Technologies by Geographic Region - US, Canada, Europe, Asia-Pacific (Including Japan), and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-861$350
   Table 25: World 14-Year Perspective for e-Clinical Trial Technologies by Geographic Region - Percentage Breakdown of Dollar Revenues for US, Canada, Europe, Asia-Pacific (Including Japan), and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-871$350
   Table 26: World Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, CTMS, ePROs, and RTSM Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-881$350
   Table 27: World Historic Review for e-Clinical Trial Technologies by Application - EDC, CTMS, ePROs, and RTSM Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-891$350
   Table 28: World 14-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Dollar Revenues for EDC, CTMS, ePROs, and RTSM Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-901$350
   Table 29: World Recent Past, Current & Future Analysis for Electronic Data Capture (EDC) by Clinical Trial Phase - Phase I, II, III, and IV Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-911$350
   Table 30: World Historic Review for Electronic Data Capture (EDC) by Clinical Trial Phase - Phase I, II, III, and IV Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-921$350
   Table 31: World 14-Year Perspective for Electronic Data Capture (EDC) by Clinical Trial Phase - Percentage Breakdown of Dollar Revenues for Phase I, II, III, and IV Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-931$350
   Table 32: World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery Mode - Web-based CTMS, Cloud-based CTMS and On-Premise CTMS Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-941$350
   Table 33: World Historic Review for Clinical Trial Management Systems (CTMS) by Delivery Mode - Web-based CTMS, Cloud-based CTMS and On-Premise CTMS Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-951$350
   Table 34: World 14-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery Mode - Percentage Breakdown of Dollar Revenues for Web-based CTMS, Cloud-based CTMS and On-Premise CTMS Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-961$350
   Table 35: World Recent Past, Current & Future Analysis for Electronic Patient Reported Outcomes (ePRO) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-971$350
   Table 36: World Historic Review for Electronic Patient Reported Outcomes (ePRO) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-981$350
   Table 37: World Recent Past, Current & Future Analysis for Randomization and Trial Supply Management (RTSM) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-991$350
   Table 38: World Historic Review for Randomization and Trial Supply Management (RTSM) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-1001$350
   A. Market Analysis.....III-1
United States: The Largest Market for e-Clinical Trial Technologies
  Worldwide.....III-1
Table 39: The US Life Science R&D Spending (In US$ Billion): 2014- 2016 (includes corresponding Graph/Chart).....III-1
1$200
   Table 40: Increased Funding for Clinical Trials and Supportive Activities in the US: 2013 to 2018 (includes corresponding Graph/Chart).....III-2
The US Leads the Pharma R&D Companies.....III-2
1$200
   Table 41: R&D Companies Distribution by Region: 2017 (includes corresponding Graph/Chart).....III-3
Drug Developers Rely on CROs to Improve Trial Efficiency and Cost Savings.....III-3
1$200
   Growing Demand from CROs Drives the CTMS Market.....III-4
Increasing Adoption of Adaptive Clinical Trials.....III-4
Risk-based Monitoring Catches Pace.....III-4
Paradigm Shift in Oncology Clinical Trial.....III-4
1$75
   New FDA Standards.....III-5
FDA Binding Guidance Comes into Effect.....III-5
1$75
   Product/Service Introductions.....III-61$75
   Strategic Corporate Developments.....III-76$450
   Select Key Players.....III-1311$825
   B. Market Analytics.....III-24
Table 42: The US Recent Past, Current & Future Analysis for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-24
1$200
   Table 43: The US Historic Review for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-251$200
   A. Market Analysis.....III-26
Current & Future Analysis.....III-26
Strategic Corporate Development.....III-26
B. Market Analytics.....III-26
Table 44: Canadian Recent Past, Current & Future Analysis for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-26
1$200
   Table 45: Canadian Historic Review for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-271$200
   A. Market Analysis.....III-28
Current & Future Analysis.....III-28
Clinical Trial Regulation to Strengthen EU’s Position in Clinical Research.....III-28
EMA Focuses on Enhancing Patient Safety in First-In-Human Clinical Trials.....III-28
1$75
   Brexit Referendum to Threaten UK’s Position as Leading Hub for Clinical
  Trials.....III-29
Strategic Corporate Development.....III-29
1$75
   Select Key Players.....III-302$150
   B. Market Analytics.....III-32
Table 46: European Recent Past, Current & Future Analysis for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-32
1$200
   Table 47: European Historic Review for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-331$200
   A. Market Analysis.....III-34
Asia-Pacific: The Fastest Growing Region for e-Clinical Trial Technologies.....III-34
Table 48: Total Number of Clinical Studies Conducted in Asia: 2017 (includes corresponding Graph/Chart).....III-34
R&D Outsourcing in Life Sciences on the Rise.....III-34
1$200
   An Overview of Key Markets.....III-35
Japan.....III-35
1$75
   China.....III-36
China Rapidly Emerges as a Compelling Destination for Clinical Trials.....III-36
India.....III-36
A Thriving Clinical Trials Market.....III-36
1$75
   Reasons for Outsourcing to India.....III-37
Approval Process in India.....III-37
1$75
   Regulatory Issues.....III-38
Improper Functioning of CROs.....III-38
Clinical Study Liabilities.....III-38
1$75
   Access to Treatment Following Clinical Trial.....III-39
Legislation to Monitor Drug Trials.....III-39
Australia.....III-39
Australia to Retain Position as Compelling Hub for Early-Phase Clinical
  Research.....III-39
1$75
   Initiatives Taken by Australian Government for Popularizing Clinical
  Trials.....III-40
Strategic Corporate Developments.....III-40
1$75
   B. Market Analytics.....III-41
Table 49: Asia-Pacific (including Japan) Recent Past, Current & Future Analysis for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-41
1$200
   Table 50: Asia-Pacific (including Japan) Historic Review for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-421$200
   A. Market Analysis.....III-43
Current & Future Analysis.....III-43
Latin America.....III-43
Strategic Corporate Development.....III-43
1$75
   B. Market Analytics.....III-44
Table 51: Rest of World Recent Past, Current & Future Analysis for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-44
1$200
   Table 52: Rest of World Historic Review for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-451$200
  
Total Companies Profiled: 84 (including Divisions/Subsidiaries - 87)

Region/Country Players

The United States 57 Canada 3 Japan 1 Europe 22 France 2 Germany 3 The United Kingdom 9 Italy 1 Rest of Europe 7 Asia-Pacific (Excluding Japan) 4
Click here to request a full table of contents and more details on this project.